Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Freshpet (FRPT)

Freshpet Q4 net sales rise 8.6% to $285.2 million; 2026 EBITDA outlook $205-215 million

Positive Impact 3 of 5 earnings Written later

Freshpet reported fourth-quarter and full-year 2025 results, with net sales up 8.6% in the quarter and 13.0% for the year, and net income well above the prior year. The company also issued 2026 guidance calling for net sales growth of 7% to 10% and Adjusted EBITDA of $205 million to $215 million, compared with Adjusted EBITDA of $195.7 million in 2025.

Key points

  • Q4 2025 net sales were $285.2 million, up 8.6%, with diluted EPS of $0.64 versus $0.36 a year earlier.
  • Full-year 2025 net sales were $1,102.0 million, up 13.0%, and free cash flow was $12.4 million, compared with negative $32.8 million in 2024.
  • Full-year 2025 net income of $139.1 million included a $68.4 million income tax benefit from the release of a valuation allowance.
  • 2026 guidance: net sales growth of 7% to 10%, Adjusted EBITDA of $205 million to $215 million, and capital expenditures of about $150 million.

The filing

CompanyFreshpet (FRPT)
Form8-K, current report
Filed with the SECFeb 23, 2026, 6:31 AM ET
Accession number0001611647-26-000002

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:49 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 23, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.